share_log

Acumen Pharmaceuticals Presented Encouraging Results For Phase 2 Of Its Clinical Trail For Alzheimer Screening Drug Sabirnetug

Acumen Pharmaceuticals Presented Encouraging Results For Phase 2 Of Its Clinical Trail For Alzheimer Screening Drug Sabirnetug

Acumen Pharmaceuticals在其用于阿尔茨海默病筛查药物Sabirnetug的临床试验第2阶段展示出令人鼓舞的结果
Benzinga ·  10/31 07:14

Acumen Pharmaceuticals Presented Encouraging Results For Phase 2 Of Its Clinical Trail For Alzheimer Screening Drug Sabirnetug

Acumen Pharmaceuticals为其阿尔茨海默病筛查药物Sabirnetug临床试验第2阶段的鼓舞人心的结果做了报告

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发